Feasibility of using machine learning on insurance claims to identify correlates of lower extremity amputation in insured adults with type 2 diabetes who initiate treatment with sodium-glucose co-transporter 2 (SGLT-2) inhibitors

Yuan Luo, Andrew J. Cooper, Raymond Kang, Ronald Ackermann. Feasibility of using machine learning on insurance claims to identify correlates of lower extremity amputation in insured adults with type 2 diabetes who initiate treatment with sodium-glucose co-transporter 2 (SGLT-2) inhibitors. In AMIA 2021, American Medical Informatics Association Annual Symposium, San Diego, CA, USA, October 30, 2021 - November 3, 2021. AMIA, 2021. [doi]

Abstract

Abstract is missing.